[[File:Benign prostatic hypertrophy world map - DALY - WHO2004.svg|thumb|Disability-adjusted life year for benign prostatic hyperplasia per 100,000 inhabitants in 2004.[tpl]cite web |url=http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html |title=WHO Disease and injury country estimates |year=2009 |work=World Health Organization |accessdate=11 November 2009[/tpl] 
 ]]
Globally, benign prostatic hyperplasia affects about 210 million males as of 2010 (6% of the population).[tpl]cite journal|last=Vos|first=Theo|author2=et al. |title=Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 |journal=The Lancet |date=1 December 2012 |volume=380 |issue=9859 |pages=2163–2196 |doi=10.1016/S0140-6736(12)61729-2 |pmid=23245607[/tpl]  The prostate gets larger in most men as they get older. For a symptom-free man of 46 years, the risk of developing BPH over the next 30 years is 45%. Incidence rates increase from 3 cases per 1000 man-years at age 45–49 years, to 38 cases per 1000 man-years by the age of 75–79 years. While the prevalence rate is 2.7% for men aged 45–49, it increases to 24% by the age of 80 years.[tpl]cite journal |last1=Verhamme |first1=K |last2=Dieleman |first2=JP |last3=Bleumink |first3=GS |last4=Van Der Lei |first4=J |last5=Sturkenboom |first5=MC |last6=Artibani |first6=W |last7=Begaud |first7=B |last8=Berges |first8=R |last9=Borkowski |first9=A |last10=Chappel |first10=C. R. |last11=Costello |first11=A |last12=Dobronski |first12=P |last13=Farmer |first13=R. D. |last14=Jiménez Cruz |first14=F |last15=Jonas |first15=U |last16=MacRae |first16=K |last17=Pientka |first17=L |last18=Rutten |first18=F. F. |last19=Van Schayck |first19=C. P. |last20=Speakman |first20=M. J. |last21=Sturkenboom |first21=M. C. |last22=Tiellac |first22=P |last23=Tubaro |first23=A |last24=Vallencien |first24=G |last25=Vela Navarrete |first25=R |title=Incidence and Prevalence of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Primary Care—The Triumph Project |journal=European Urology |volume=42 |issue=4 |pages=323–8 |year=2002 |pmid=12361895 |doi=10.1016/S0302-2838(02)00354-8|display-authors=8 |author26=Triumph Pan European Expert Panel [/tpl]

==References==

==Further reading==

==External links==


